GINA Global Strategy for Asthma Management and Prevention 2021 simplified.
Global Initiative for Asthma (GINA) Global Strategy for Asthma Management and Prevention 2021 GINA was established by the WHO and NHLBI in 1993. COVID-19 & Asthma People with asthma do not appear to be at increased risk of acquiring COVID-19 Overall, people with well-controlled asthma are not at increased risk of COVID-19-related death However, the risk of COVID-19 death was increased in people who had recently needed oral corticosteroids (OCS) for their asthma. For patients with severe asthma, continue biologic therapy or oral corticosteroids if prescribed About Asthma Asthma is the most common chronic non-communicable disease, affecting over 260 million people globally in 2019 Asthma is characterized by variable respiratory symptoms such as wheeze, shortness of breath, chest tightness and cough, and variable expiratory airflow limitation. It is usually associated with airway inflammation People with asthma often have periods of worsening symptoms and worsening a
